Home›Companies›Biotech & Pharma›Myrobalan Therapeutics Holding

Myrobalan Therapeutics Holding, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 24, 2024·Suggest an edit

About Myrobalan Therapeutics Holding

Myrobalan Therapeutics Holding is a private company based in Medford, Massachusetts, incorporated in 2023 in Delaware. It has reported $24,049,258 raised in one offering on Form D since January 2024. Its chief executive is Jing Yu Wang.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 9, 2024Jan 24, 2024$24,049,258fully sold12$2.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Myrobalan Therapeutics Holding's Form D filed Jan 24, 2024.

GF
Guoping Feng
Director
MY
Minmin Yang
Director
ZH
Zhigang He
Director
JW
Jing Yu Wang
Chief Executive Officer and director
SY
Shixiang Yan
Director

Sources

  1. SECMyrobalan Therapeutics Holding, Inc. filing history